Breast Cancer — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for breast cancer. 73 active patents protecting 2 drugs from 2+ originators. First major cliff: 2029. Daily refresh.

2
Approved drugs
73
Active US patents
46/100
Avg vulnerability
$182M
Annual revenue covered

Originators in Breast Cancer

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Pfizer Inc. 70 patents MYLAN SEIYAKU Ltd 3 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating breast cancer. Each bar = one year. Y-axis scaled to peak year (46 patents).

46
29
24
31

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Talzenna
Talazoparib Tosylate
Pfizer Inc. 70 37 $182M 2029-07-27
Paraplatin
Carboplatin
MYLAN SEIYAKU Ltd 3 55 2045-04-01

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
10780088 Talzenna method of use 81 2029-07-27
10780088 Talzenna method of use 81 2029-07-27
9820985 Talzenna method of use 81 2029-07-27
10780088 Talzenna method of use 81 2029-07-27
10780088 Talzenna method of use 81 2029-07-27
10780088 Talzenna method of use 81 2029-07-27
9820985 Talzenna method of use 81 2029-07-27
9820985 Talzenna method of use 81 2029-07-27
10780088 Talzenna method of use 81 2029-07-27
9820985 Talzenna method of use 81 2029-07-27

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8735392 Talzenna composition of matter 10 2031-10-20
8735392 Talzenna composition of matter 10 2031-10-20
8735392 Talzenna composition of matter 10 2031-10-20
8735392 Talzenna composition of matter 10 2031-10-20
10189837 Talzenna composition of matter 10 2031-10-20
10189837 Talzenna composition of matter 10 2031-10-20
10189837 Talzenna composition of matter 10 2031-10-20
10189837 Talzenna composition of matter 10 2031-10-20
8012976 Talzenna composition of matter 10 2029-07-27
8012976 Talzenna composition of matter 10 2029-07-27

Related